PONTE VEDRA BEACH – Trey Mullinax’s 2026 season had amounted to two missed cuts by the time late April arrived. On Tuesday, the PGA Tour confirmed that the next one will not start until January.
The Tour suspended the 34-year-old for six months after he tested positive for a substance prohibited by the World Anti-Doping Agency, the penalty effective July 29. Mullinax is eligible to return January 16, 2027, a date that falls well past the close of this season and into the next. He cooperated fully throughout the process and accepted the suspension, the Tour confirmed in its official announcement.
What sent his season into a six-month void, by his own account, was medication he had been taking for a condition first diagnosed in college. He never sought the therapeutic use exemption that would have made the same substance permissible under Tour policy. When a drug test returned positive, the process that followed was swift.
The Tour’s anti-doping program has been in place since 2008, part of a WADA-aligned framework that professional golf adopted later than most Olympic disciplines. Mullinax is believed to be the ninth player suspended under it, Yahoo Sports reported. The previous case came in October 2023, when Byeong Hun An tested positive for a prohibited substance contained in an over-the-counter cough syrup – another instance where the violation stemmed from inattention rather than deliberate enhancement. Strict liability, the bedrock of credible anti-doping enforcement, treated An’s case and Mullinax’s identically. That is how the system is designed to work.
Mullinax’s statement, released alongside the Tour’s announcement, made no attempt to minimize the failure. “I take full responsibility for what happened,” he said. “I recently used a medication to treat a condition I was originally diagnosed with in college without seeking approval under the Tour’s Anti-Doping Policy. My lack of knowledge is not an excuse. It was my responsibility to know the rules before taking any medication and I failed to do so.”
The one point he pressed hard was intent. “I have never taken any substance with the intention of gaining a competitive advantage,” he said. “Anyone who knows me knows how much I respect this game and the values it represents. I accept the consequences of my actions and will use this experience as a lesson.”
Mullinax’s career win came at the 2022 Barbasol Championship, his lone PGA Tour title in a professional career that began after he turned professional in 2013. He earned his Tour card through the Korn Ferry Tour and spent most of his career in the middle tiers of the PGA Tour’s performance hierarchy. By 2026, he was operating on conditional status after finishing 150th in the FedEx Cup standings in 2025. He played only three times this spring, missing the cut in both solo-entry events he entered. His last appearance was at the Zurich Classic of New Orleans on April 27. The suspension renders whatever remained of his 2026 schedule irrelevant.
The Tour’s anti-doping policy requires players to obtain a therapeutic use exemption before using any substance on the WADA prohibited list. The process demands advance documentation filed before a positive test occurs. The burden falls entirely on the player, and the standard holds regardless of how legitimate the underlying medical need proves to be. The pattern mirrors what anti-doping enforcement across professional sport has demonstrated repeatedly – prescribed medications account for a growing share of sanction cases, and the strict-liability framework offers no accommodation for intent once a sample tests positive. The Tour has not disclosed the specific substance Mullinax used or described his condition beyond what he said himself. Whether that substance has any plausible relationship to on-course performance is a question the policy does not publicly address.
The PGA Tour has spent much of this summer reshaping its institutional relationships. A multi-year strategic alliance with the DP World Tour and Asian Tour, formalized in July, extended the network of circuits players can move through and restructured how world-ranking points flow across the global game. None of that work adjusts the calculus for a player on conditional status returning from a six-month absence into a field where available starts are rationed tightly. Mullinax will be eligible January 16. Whether that eligibility translates into competitive PGA Tour golf is the part this suspension does not answer.
